During the last session, Tiziana Life Sciences Ltd (NASDAQ:TLSA)’s traded shares were 4.64 million, with the beta value of the company hitting 0.69. At the end of the trading day, the stock’s price was $0.80, reflecting an intraday gain of 8.51% or $0.07. The 52-week high for the TLSA share is $1.74, that puts it down -117.5 from that peak though still a striking 48.75% gain since the share price plummeted to a 52-week low of $0.41. The company’s market capitalization is $88.18M, and the average intraday trading volume over the past 10 days was 0.4 million shares, and the average trade volume was 377.91K shares over the past three months.

Tiziana Life Sciences Ltd (TLSA) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. TLSA has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.

Tiziana Life Sciences Ltd (NASDAQ:TLSA) trade information

Tiziana Life Sciences Ltd (TLSA) registered a 8.51% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 8.51% in intraday trading to $0.80, hitting a weekly high. The stock’s 5-day price performance is 9.92%, and it has moved by -19.51% in 30 days. Based on these gigs, the overall price performance for the year is 36.64%. The short interest in Tiziana Life Sciences Ltd (NASDAQ:TLSA) is 0.68 million shares and it means that shorts have 1.55 day(s) to cover.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -12.98%.

TLSA Dividends

Tiziana Life Sciences Ltd is due to release its next quarterly earnings in February. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Also, the Mutual Funds coming in first place with the largest holdings of Tiziana Life Sciences Ltd (TLSA) shares are Fidelity NASDAQ Composite Index ETF and Fidelity NASDAQ Composite Index Fund . Data provided on Nov 30, 2024 indicates that Fidelity NASDAQ Composite Index ETF owns about 164.81 shares. This amounts to just over 0.16 percent of the company’s overall shares, with a $0.13 million market value. The same data shows that the other fund manager holds slightly less at 55.88, or about 0.05% of the stock, which is worth about $44533.0.